PerkinElmer and IDBS Announce Software Collaboration to Improve High Content Screening Outcomes for Drug Discovery Research
IDBS announced a collaboration with PerkinElmer, Inc. at the 6th Annual High Content Analysis Conference in San Francisco. The collaboration will be focused on improving data analysis and interpretation of High Content Screening (HCS), an enabling technology in the search for key cellular markers associated with human health and disease.
“The future of High Content Screening lies in an increased synergy between technologies that integrate vast image content with large compound sets, to generate actionable research data,” said Richard M. Eglen, Ph.D., president, Bio-discovery, PerkinElmer. “We feel this collaboration with IDBS is a timely and highly promising advance in giving researchers access to greater insights into the cell-based mechanisms of disease, as well as development of novel therapies based on greater understanding of the origins of diseases.”
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
